Invests at least 80% of its assets in dividend-paying common stocks of U.S. companies. Manages an actively diversified portfolio, typically holding 30 to 50 stocks. Now — the numbers.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
No real growth (-1% a year). Red columns mark years that ended in a loss.
This company is not turning a profit, so the market is pricing its sales instead: 6.3× for every dollar of annual revenue.
No analyst target is on record for this company.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
Sales run at $53.4M a year. A small number, but proof the product has real buyers.
A loss of $44.7M against $53.4M in annual sales.
We grade companies — revenue, margins, balance sheets. This is a fund, so there is no report card to give. That is not a low grade; it is a different kind of thing.
One-line summary: a basket, not a business. Judge it by what it holds.